Connect with us

Health

Labat and CSIR Collaborate to Ramp Up Hemp Production in SA

mm

Updated

 on

Labat Africa is partnering with the Council for Scientific and Industrial Research (CSIR) to study and commercialize medicinal cannabis and industrial hemp in the African market. Labat is an African-based venture capital company that is currently listed on the Venture Capital Market of the Johannesburg Stock Exchange (“JSE”). The CSIR is South Africa’s premier research and development organization. Under this agreement, the CSIR will be able to ramp up the production and commercialization of medicinal cannabis and industrial hemp.

According to Labat’s CEO Brian van Rooyen, this agreement will solidify the collaboration between the two organizations in the value chain across the pharmaceutical, textile, and energy industries.

CSIR’s Coega hemp-processing facility will be used, upgraded, and expanded to accelerate the production of hemp biomass and the conversion into biocomposites for value-addition in the automotive, construction, textile, and packaging industries. Van Rooyen reported that a number of private sector and state-owned enterprises have confirmed interest. The largest textile manufacturing company in South Africa has promised to use the hemp material for their production rollout.

Africa is lagging behind in the legalization, production, and use of hemp and hemp products. South Africa has a cottage industry that has suffered the consequences of decades of stigma. As of now, there is no large-scale hemp production facilities and the small facilities that exist lack technological and financial capabilities for scaling. The joint effort by the CSIR and Labat is bound to reduce stigma and open up the hemp industry not only in South Africa but the rest of the continent. .

 

close

MyCannabis.com News!

We’d love to keep you updated with our latest cannabis news, industry interviews, and offers.

We don’t spam! Read our privacy policy for more info.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: MyCannabis.com is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.